PDF(Pubmed)
Abstract：
The Worldwide Index of Serotype Specific Pneumococcal Antibody Responses (WISSPAR; https://wisspar.com), is a centralized, online platform housing data on immunogenicity from clinical trials of pneumococcal vaccines. The data on WISSPAR are primarily curated from outcomes tables from clinical trials and are made available in a searchable format that can be readily used for downstream analyses. The WISSPAR database includes trials covering numerous vaccine products, manufacturers, dosing schedules, age groups, immunocompromised groups, and geographic regions. Customizable data visualization tools are embedded within the site, or the data can be exported for further analyses. Users can also browse summary information about the clinical trials and their results. WISSPAR provides a platform for analysts and policy makers to efficiently gather, compare, and collate clinical trial data about pneumococcal vaccines.
摘要：
血清型特异性肺炎球菌抗体反应的全球指数（WISSPAR;https://wisspar.com），是一个集中的，在线平台上收集来自肺炎球菌疫苗临床试验的免疫原性数据。WISSPAR的数据主要来自临床试验的结果表，并以可搜索的格式提供，可轻松用于下游分析。WISSPAR数据库包括涵盖众多疫苗产品的试验，制造商,给药时间表，年龄组,免疫受损的群体，和地理区域。可定制的数据可视化工具嵌入在网站中，或者可以导出数据进行进一步分析。用户还可以浏览有关临床试验及其结果的摘要信息。WISSPAR为分析师和政策制定者提供了一个有效收集的平台，比较,并整理有关肺炎球菌疫苗的临床试验数据。
